Rosell R - Search Results

1

Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.

Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM. Mazieres J, et al. Among authors: rosell r. Cancer Res. 2004 Jul 15;64(14):4717-20. doi: 10.1158/0008-5472.CAN-04-1389. Cancer Res. 2004. PMID: 15256437

2

Molecular staging of non-small cell lung cancer according to K-ras genotypes.

Rosell R, Monzó M, Pifarré A, Ariza A, Sánchez JJ, Moreno I, Maurel J, López MP, Abad A, de Anta JM. Rosell R, et al. Clin Cancer Res. 1996 Jun;2(6):1083-6. Clin Cancer Res. 1996. PMID: 9816271

3

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Esteller M, et al. Among authors: rosell r. Cancer Res. 1999 Jan 1;59(1):67-70. Cancer Res. 1999. PMID: 9892187

4

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Lord RV, Brabender J, Gandara D, Alberola V, Camps C, Domine M, Cardenal F, Sánchez JM, Gumerlock PH, Tarón M, Sánchez JJ, Danenberg KD, Danenberg PV, Rosell R. Lord RV, et al. Among authors: rosell r. Clin Cancer Res. 2002 Jul;8(7):2286-91. Clin Cancer Res. 2002. PMID: 12114432 Clinical Trial.

5

DNA repair and cisplatin resistance in non-small-cell lung cancer.

Rosell R, Lord RV, Taron M, Reguart N. Rosell R, et al. Lung Cancer. 2002 Dec;38(3):217-27. doi: 10.1016/s0169-5002(02)00224-6. Lung Cancer. 2002. PMID: 12445742 Review.

6

Molecular predictors of response to chemotherapy in lung cancer.

Rosell R, Taron M, Ariza A, Barnadas A, Mate JL, Reguart N, Margel M, Felip E, Méndez P, García-Campelo R. Rosell R, et al. Semin Oncol. 2004 Feb;31(1 Suppl 1):20-7. doi: 10.1053/j.seminoncol.2003.12.011. Semin Oncol. 2004. PMID: 14981577 Review.

7

Cloning and characterization of the promoter of human Wnt inhibitory factor-1.

Reguart N, He B, Xu Z, You L, Lee AY, Mazieres J, Mikami I, Batra S, Rosell R, McCormick F, Jablons DM. Reguart N, et al. Among authors: rosell r. Biochem Biophys Res Commun. 2004 Oct 8;323(1):229-34. doi: 10.1016/j.bbrc.2004.08.075. Biochem Biophys Res Commun. 2004. PMID: 15351726

8

The promise of pharmacogenomics: gemcitabine and pemetrexed.

Rosell R, Taron M, Sanchez JM, Moran T, Reguart N, Besse B, Isla D, Massuti B, Alberola V, Sanchez JJ. Rosell R, et al. Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):70-6. Oncology (Williston Park). 2004. PMID: 15655942 Free article. Review.

9

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.

Rosell R, Ichinose Y, Taron M, Sarries C, Queralt C, Mendez P, Sanchez JM, Nishiyama K, Moran T, Cirauqui B, Mate JL, Besse B, Reguart N, Perez M, Sanchez JJ. Rosell R, et al. Lung Cancer. 2005 Oct;50(1):25-33. doi: 10.1016/j.lungcan.2005.05.017. Lung Cancer. 2005. PMID: 16011858

10

Wnt signaling in stem cells and non-small-cell lung cancer.

He B, Barg RN, You L, Xu Z, Reguart N, Mikami I, Batra S, Rosell R, Jablons DM. He B, et al. Among authors: rosell r. Clin Lung Cancer. 2005 Jul;7(1):54-60. doi: 10.3816/CLC.2005.n.022. Clin Lung Cancer. 2005. PMID: 16098245 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters